Neuropathology for the Neuroradiologist: Palisades and Pseudopalisades

References

1. ↵
   Zülch KJ. Histology of brain tumors. In: Brain Tumors: Their Biology and Pathology. Berlin, Germany: Springer-Verlag;1986 :118–34
2. ↵
   Verocay J. Zur kenntnis der “neurofibrome.” Beitr Pathol Anat 1910;48:1–69

   Web of Science
3. ↵
   Enstable-Puig JF, de Estable-Puig RF, Haymaker W. Jose Verocay: pioneer Uruguayan neuropathologist [in Spanish]. Arch Fund Roux Ocefa 1970;4:135–38

   PubMed
4. ↵
   Burger PC, Scheithauer BW, Vogel FS. The brain: tumors. In: Surgical Pathology of the Nervous System and Its Coverings. New York: Churchill Livingstone;2002 :160–378
5. Citow JS. Wollman RL, Macdonald RL, et al. Oncology. In: Neuropathology and Neuroradiology: A Review. New York: Thieme;2001 :46–108
6. Harkin JC, Reed RJ. Solitary benign nerve sheath tumors. In: Atlas of Tumor Pathology: Tumors of the Peripheral Nervous System. Washington, D.C: Armed Forces Institute of Pathology;1968 :29–65
7. ↵
   Ellison D, Love S, Chimelli L, et al. Peripheral nerve sheath neoplasms. In: Neuropathology: A reference Text of CNS Pathology. Edinburgh, Scotland: Mosby;2004 :695–702
8. ↵
   Reibel J, Wewer U, Albrechtsen R. The pattern of distribution of laminin in neurogenic tumors, granular cell tumors, and nevi of the oral mucosa. Acta Pathol Microbiol Immunol Scand [A] 1985;93:41–47

   PubMed
9. ↵
   Roberts DD, Wewer UM, Liotta LA, et al. Laminin-dependent and laminin-independent adhesion of human melanoma cells to sulfatides. Cancer Res 1988;48:3367–73

   Abstract/FREE Full Text
10. Beck K, Hunter I, Engel J. Structure and function of laminin: anatomy of a multidomain glycoprotein. FASEB J 1990;4:148–60

    Abstract
11. Petruzzelli L, Takami M, Humes HD. Structure and function of cell adhesion molecules. Am J Med 1999;106:467–76

    CrossRefPubMedWeb of Science
12. Yamagata M, Sanes JR, Weiner JA. Synaptic adhesion molecules. Curr Opin Cell Biol 2003;15:621–32

    CrossRefPubMedWeb of Science
13. ↵
    Miettinen M, Foidart JM, Ekblom P. Immunohistochemical demonstration of laminin, the major glycoprotein of basement membranes, as an aid in the diagnosis of soft tissue tumors. Am J Clin Pathol 1983;79:306–11

    PubMedWeb of Science
14. ↵
    Weiner JA, Fukushima N, Contos JJ, et al. Regulation of Schwann cell morphology and adhesion by receptor-mediated lysophosphatidic acid signaling. J Neurosci 2001;21:7069–78

    Abstract/FREE Full Text
15. ↵
    Erlandson RA, Woodruff JM. Peripheral nerve sheath tumors: an electron microscopic study of 43 cases. Cancer 1982;49:273–87

    CrossRefPubMedWeb of Science
16. ↵
    Chen SY, Miller AS. Neurofibroma and schwannoma of the oral cavity: a clinical and ultrastructural study. Oral Surg Oral Med Oral Pathol 1979;47:522–28

    PubMed
17. ↵
    Kinoshita S, Hirai A, Izaki S, et al. Leiomyosarcoma of the skin with generalized metastases: electron microscopic and immunohistochemical study. J Dermatol 1991;18:654–60

    PubMed
18. Reed RJ, Fine RM, Meltzer HD. Palisaded, encapsulated neuromas of the skin. Arch Dermatol 1972;106:865–70

    CrossRefPubMedWeb of Science
19. Zamecnik M, Michal M. Solitary fibrous tumor (fibrous mesothelioma): report of 2 cases in an extraserous location [in Slovak]. Cesk Patol 1998;34:58–62

    PubMed
20. Schwob VS, Santa Cruz DJ. Palisading cutaneous fibrous histiocytoma. J Cutan Pathol 1986;13:403–07

    CrossRefPubMedWeb of Science
21. Allen PW. Subcutaneous spindle cell lipoma. In: Tumors and Proliferations of Adipose Tissue: A Clinickopathologic Approach. New York: Masson;1981 :20–26
22. Akasaka T, Imamura Y, Mori Y, et al. Trichoblastoma with rippled-pattern. J Dermatol 1997;24:174–78

    PubMed
23. San Juan J, Monteagudo C, Navarro P, et al. Basal cell carcinoma with prominent central palisading of epithelial cells mimicking schwannoma. J Cutan Pathol 1999;26:528–32

    PubMed
24. Graham BS, Barr RJ. Rippled-pattern sebaceous trichoblastoma. J Cutan Pathol 2000;27:455–59

    PubMed
25. Lespi PJ, Smit R. Verocay body–prominent cutaneous leiomyoma. Am J Dermatopathol 1999;21:110–11

    PubMed
26. Baugh W, Quigley MM, Barrett TL. Palisaded angioleiomyoma. J Cutan Pathol 2000;27:526–28

    PubMed
27. Zelger BG, Steiner H, Kutzner H, et al. Verocay body–prominent cutaneous schwannoma. Am J Dermatopathol 1997;19:242–49

    PubMed
28. Dabski C, Reiman HM Jr, Muller SA. Neurofibrosarcoma of skin and subcutaneous tissues. Mayo Clin Proc 1990;65:164–72

    PubMedWeb of Science
29. Ahn SK, Chang SN, Lee SH, et al. Verocay bodies in neurofibroma. Int J Dermatol 1994;33:886–87

    PubMed
30. Radulescu D, Sarbu M. Giant congenital nevi: a clinical and histopathological study. Rom J Morphol Embryol 1994;40:19–22

    PubMed
31. Misago N, Narisawa Y. Rippled-pattern sebaceoma. Am J Dermatopathol 2001;23:437–43

    PubMed
32. Llatjos R, Fernandez-Figueras MT, Diaz-Cascajo C, et al. Palisading and Verocay body–prominent dermatofibrosarcoma protuberans: a report of three cases. Histopathology 2000;37:452–55

    CrossRefPubMedWeb of Science
33. Pearson JP, Weiss SW, Headington JT. Cutaneous malignant melanotic neurocristic tumors arising in neurocristic hamartomas: a melanocytic tumor morphologically and biologically distinct from common melanoma. Am J Surg Pathol 1996;20:665–77

    CrossRefPubMedWeb of Science
34. ↵
    Sexton M, Maize JC. Malignant melanoma simulating Schwannian differentiation. Am J Dermatopathol 1985;7(suppl):171–76

    PubMed
35. ↵
    Casadei GP, Scheithauer BW, Hirose T, et al. Cellular schwannoma: a clinicopathologic, DNA flow cytometric, and proliferation marker study of 70 patients. Cancer 1995;75:1109–19

    PubMed
36. ↵
    Burger PC, Scheithauer BW. Tumors of the peripheral nerve sheath. In: Atlas of Tumor Pathology: Tumors of the Central Nervous System. Washington, DC: Armed Forces Institute of Pathology;1994 :333–43
37. ↵
    Russell DS, Cairns H. Polar spongioblastomas [in Spanish]. Arch Histol Norm Patol 1947;3:423–41
38. ↵
    Schiffer D, Cravioto H, Giordana MT, et al. Is polar spongioblastoma a tumor entity? J Neurosurg 1993;78:587–91

    PubMed
39. ↵
    Kleihues P, Cavenee W, eds. World Health Organization Classification of tumours: Pathology and Genetics—Tumours of the Nervous System. Lyon, France: IARC Press;2000
40. ↵
    Brat DJ, Mapstone TB. Malignant glioma physiology: cellular response to hypoxia and its role in tumor progression. Ann Intern Med 2003;138:659–68

    CrossRefPubMedWeb of Science
41. ↵
    Plate KH, Breier G, Weich HA, et al. Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo. Nature 1992;359:845–48

    CrossRefPubMedWeb of Science
42. ↵
    Brat DJ, Van Meir EG. Vaso-occlusive and prothrombotic mechanisms associated with tumor hypoxia, necrosis, and accelerated growth in glioblastoma. Lab Invest 2004;84:397–405

    CrossRefPubMedWeb of Science
43. ↵
    Wharton SB, McNelis U, Bell HS, et al. Expression of poly(ADP-ribose) polymerase and distribution of poly(ADP-ribosyl)ation in glioblastoma and in glioma multicellular tumor spheroid model. Neuropathol Appl Neurobiol 2000;26:528–35

    CrossRefPubMedWeb of Science
44. ↵
    Seilhean D, DeGirolami U, Gray F. Basic pathology of the central nervous system. In: Gray F, DeGirolami U, Poirer J, eds. Escourolle and Poirer’s Manual of Basic Neuropathology. Philadelphia: Butterworth Heinemann;2004 :1–20
45. ↵
    Brat DJ, Castellano-Sanchez AA, Hunter SB, et al. Pseudopalisades in glioblastoma are hypoxic, express extracellular matrix proteases, and are formed by an actively migrating cell population. Cancer Res 2004;64:920–27

    Abstract/FREE Full Text
46. ↵
    Brat DJ, Castellano-Sanchez A, Hunter SB, et al. Pseudopalisading cells in glioblastoma are hypoxic and could represent a rapidly migrating population. Paper presented at: Society for Neuro-Oncology Eighth Annual Meeting; November 13–16,2003; Keystone, Colo
47. ↵
    Shweiki D, Itin A, Soffer D, et al.. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature 1992;359:843–45

    CrossRefPubMedWeb of Science
48. Brat DJ, Castellano-Sanchez A, Kaur B, et al. Genetic and biologic progression in astrocytomas and their relation to angiogenic dysregulation. Adv Anat Pathol 2002;9:24–36

    CrossRefPubMedWeb of Science
49. Takano S, Yoshii Y, Kondo S, et al. Concentration of vascular endothelial growth factor in the serum and tumor tissue of brain tumor patients. Cancer Res 1996;56:2185–90

    Abstract/FREE Full Text
50. ↵
    Maxwell PH, Pugh CW, Ratcliffe PJ. Activation of the HIF pathway in cancer. Curr Opin Genet Dev 2001;11:293–99

    CrossRefPubMedWeb of Science
51. ↵
    Folkman J, What is the evidence that tumors are angiogenesis dependent? J Natl Cancer Inst 1990;82:4–6

    FREE Full Text